141 related articles for article (PubMed ID: 28815210)
21. Structural basis of lipid binding for the membrane-embedded tetraacyldisaccharide-1-phosphate 4'-kinase LpxK.
Emptage RP; Tonthat NK; York JD; Schumacher MA; Zhou P
J Biol Chem; 2014 Aug; 289(35):24059-68. PubMed ID: 25023290
[TBL] [Abstract][Full Text] [Related]
22. Robust Suppression of Lipopolysaccharide Deficiency in Acinetobacter baumannii by Growth in Minimal Medium.
Nagy E; Losick R; Kahne D
J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31451545
[TBL] [Abstract][Full Text] [Related]
23. Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on IS
Olmeda-López H; Corral-Lugo A; McConnell MJ
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680840
[TBL] [Abstract][Full Text] [Related]
24. BonA from
Grinter R; Morris FC; Dunstan RA; Leung PM; Kropp A; Belousoff M; Gunasinghe SD; Scott NE; Beckham S; Peleg AY; Greening C; Li J; Heinz E; Lithgow T
mBio; 2021 Aug; 12(4):e0148021. PubMed ID: 34311571
[TBL] [Abstract][Full Text] [Related]
25. Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.
López-Rojas R; García-Quintanilla M; Labrador-Herrera G; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2016 Jun; 47(6):473-7. PubMed ID: 27179817
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of potent Gram-negative specific LpxC inhibitors.
Mansoor UF; Vitharana D; Reddy PA; Daubaras DL; McNicholas P; Orth P; Black T; Siddiqui MA
Bioorg Med Chem Lett; 2011 Feb; 21(4):1155-61. PubMed ID: 21273067
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
[TBL] [Abstract][Full Text] [Related]
28. Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
Sutton KA; Breen J; MacDonald U; Beanan JM; Olson R; Russo TA; Schultz LW; Umland TC
Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1736-44. PubMed ID: 26249354
[TBL] [Abstract][Full Text] [Related]
29. Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells.
Kim CH; Jeong YJ; Lee J; Jeon SJ; Park SR; Kang MJ; Park JH; Park JH
Microb Pathog; 2013 Jan; 54():20-5. PubMed ID: 22982140
[TBL] [Abstract][Full Text] [Related]
30. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.
Elhosseiny NM; El-Tayeb OM; Yassin AS; Lory S; Attia AS
Int J Med Microbiol; 2016 Dec; 306(8):633-641. PubMed ID: 27713027
[TBL] [Abstract][Full Text] [Related]
31. Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
Warmus JS; Quinn CL; Taylor C; Murphy ST; Johnson TA; Limberakis C; Ortwine D; Bronstein J; Pagano P; Knafels JD; Lightle S; Mochalkin I; Brideau R; Podoll T
Bioorg Med Chem Lett; 2012 Apr; 22(7):2536-43. PubMed ID: 22401863
[TBL] [Abstract][Full Text] [Related]
32. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH
Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290
[TBL] [Abstract][Full Text] [Related]
33. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii.
Yun SH; Choi CW; Kwon SO; Park GW; Cho K; Kwon KH; Kim JY; Yoo JS; Lee JC; Choi JS; Kim S; Kim SI
J Proteome Res; 2011 Feb; 10(2):459-69. PubMed ID: 21053951
[TBL] [Abstract][Full Text] [Related]
34. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
Cortez-Cordova J; Kumar A
Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
[TBL] [Abstract][Full Text] [Related]
35. A model for the proteolytic regulation of LpxC in the lipopolysaccharide pathway of Escherichia coli.
Emiola A; Falcarin P; Tocher J; George J
Comput Biol Chem; 2013 Dec; 47():1-7. PubMed ID: 23831517
[TBL] [Abstract][Full Text] [Related]
36. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
37. Heterologous expression of 3-O-deacylase in Acinetobacter baumannii modulates the endotoxicity of lipopolysaccharide.
Badmasti F; Shahcheraghi F; Siadat SD; Bouzari S; Ajdary S; Amin M; Halabian R; Imani Fooladi AA
J Mol Microbiol Biotechnol; 2015; 25(1):37-44. PubMed ID: 25677974
[TBL] [Abstract][Full Text] [Related]
38. Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.
Fiester SE; Nwugo CC; Penwell WF; Neary JM; Beckett AC; Arivett BA; Schmidt RE; Geiger SC; Connerly PL; Menke SM; Tomaras AP; Actis LA
Infect Immun; 2015 Apr; 83(4):1354-65. PubMed ID: 25605767
[TBL] [Abstract][Full Text] [Related]
39. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
Kim Y; Bae IK; Jeong SH; Yong D; Lee K
Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
[TBL] [Abstract][Full Text] [Related]
40. Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.
Mdluli KE; Witte PR; Kline T; Barb AW; Erwin AL; Mansfield BE; McClerren AL; Pirrung MC; Tumey LN; Warrener P; Raetz CR; Stover CK
Antimicrob Agents Chemother; 2006 Jun; 50(6):2178-84. PubMed ID: 16723580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
